
P&F secures FDA approval for TRICAV II pivotal clinical trial for severe tricuspid regurgitation
TRICAV II will evaluate the safety and effectiveness of the TricValveยฎ Transcatheter Bicaval Valve System Wilmington, Delaware, Dec. 12, 2025 โ P&F USA, Inc., the U.S. subsidiary of global heart valve manufacturer P&F Products and Features GmbH, today announced that the U.S. Food and Drug

